600518.SHG Kangmei Pharmaceutical Co Ltd

Healthcare Pharmaceuticals Shanghai Stock Exchange
1.37 CNY
Close of Nov 5, 2026
1.16 2.16
Market cap
CNY 18.9B
P/E
137.0x
P/B
2.51x
ROE
1.7%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is 600518.SHG undervalued?

Graham number

The Graham number of Kangmei Pharmaceutical Co Ltd cannot be estimated reliably (the estimate is too far from the market price).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Kangmei Pharmaceutical Co Ltd fundamental analysis

No fundamental analysis for Kangmei Pharmaceutical Co Ltd yet.

Kangmei Pharmaceutical Co Ltd stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Kangmei Pharmaceutical Co Ltd

Kangmei Pharmaceutical Co., Ltd. produces and sells Chinese herbal medicines in China. The company offers Chinese patent medicines, chemical medicines, and health food products. It also engages in the operation of Chinese medicinal materials markets; production and sale of medical devices; and operation of pharmaceutical logistics system. The company provides its products through medical institution resources, smart pharmacies, OTC retail, chain drug stores, direct sales, me…

Full company profile